New Delhi: The Director-General of the Indian Council of Medical Research, Balram Bhargava said that there is no benefit of plasma therapy in arresting mortality in moderate to severe cases of COVID-19.
Convalescent plasma therapy has also not been recommended by the Ministry of Health as a mainstay of COVID-19 therapy and there is no proposal under consideration to set up plasma banks.
In a press conference, Bhargava further informed about the development of horse serum, and clearance for the clinical trial has been given.
“An ICMR study has clearly established in arresting mortality in moderate to severe cases of Covid-19. Following a cue from it, we have developed horse serum, for which we have got clearance for a clinical trial,” expressed Bhargava.